Dominate opioid and xylazine (aka tranq) withdrawal in the hospital with expert insights from Dr. Joseph D’Orazio (@dorazepam) recorded LIVE! at Pennsylvania Hospital Grand Rounds in Philadephia, PA. Xylazine, an alpha-2 adrenergic agonist, has emerged as a frequent contaminant in the opioid supply with a distinct withdrawal syndrome. You’ll learn to manage this common withdrawal syndrome while also addressing acute pain complaints and opioid withdrawal. Sorry, no CME for this episode, but check out CME for past episodes at curbsiders.vcuhealth.org. Patreon | Episodes | Subscribe | Spotify | YouTube | Newsletter | Contact | Swag! | CME Show Segments Intro Xylazine basics Management of xylazine withdrawal Opioid withdrawal and acute pain Outpatient considerations for xylazine Audience questions Outro Credits Writer and Producer: Matthew Watto MD, FACP Infographic and Cover Art: Matthew Watto MD, FACP Hosts: Matthew Watto MD, FACP; Paul Williams MD, FACP Reviewer: Emi Okamoto MD Showrunners: Matthew Watto MD, FACP; Paul Williams MD, FACP Technical Production: PodPaste Guest: Joseph D’Orazio MD Full transcript available HERE

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related